Literature DB >> 27444027

Symptomatic peripheral artery disease is associated with decreased long-term survival after coronary artery bypass: a contemporary retrospective analysis.

Teruya Nakamura1, Koichi Toda1, Shigeru Miyagawa1, Yasushi Yoshikawa1, Satsuki Fukushima1, Shunsuke Saito1, Daisuke Yoshioka1, Shin Yajima1, Shohei Yoshida1, Yoshiki Sawa2.   

Abstract

PURPOSE: Little has been documented about whether the severity of peripheral artery disease (PAD) affects the postoperative outcomes of coronary artery bypass grafting (CABG).
METHODS: We performed a retrospective analysis of 683 patients who underwent isolated CABG, comparing preoperative profiles and postoperative outcomes between patients with PAD (n = 116) and those without PAD (n = 567). Kaplan-Meier analysis was done to examine the long-term survival and the Cox proportional hazard model was used to establish the preoperative risk factors associated with survival.
RESULTS: The PAD patients were older and had more preoperative comorbidities than those without PAD. There were three operative deaths in each group (p = 0.07). The patients with PAD had more postoperative complications related to transfusion requirement (p = 0.004), the need for re-exploration for bleeding (p = 0.04), longer ventilation time (p < 0.001), and longer ICU stay (p = 0.001), than those without PAD. The 10-year survival rate of the PAD patients was lower than that of the non-PAD patients (p < 0.001). Univariate and multivariate analyses revealed that symptomatic PAD (p = 0.008) was associated with decreased long-term survival.
CONCLUSION: Symptomatic PAD was found to be an independent factor for poor long-term survival after CABG. Thus, aggressive screening measures for coronary disease, early surgical revascularization, and secondary prevention may improve the early and long-term outcomes of these patients.

Entities:  

Keywords:  Coronary artery bypass; Coronary artery disease; Peripheral artery disease

Mesh:

Year:  2016        PMID: 27444027     DOI: 10.1007/s00595-016-1379-4

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  30 in total

1.  Comparison of coronary bypass surgery with and without cardiopulmonary bypass in patients with multivessel disease.

Authors:  Michael J Mack; Albert Pfister; Donna Bachand; Robert Emery; Mitchell J Magee; Mark Connolly; Valavanur Subramanian
Journal:  J Thorac Cardiovasc Surg       Date:  2004-01       Impact factor: 5.209

2.  Prevalence and clinical implications of newly revealed, asymptomatic abnormal ankle-brachial index in patients with significant coronary artery disease.

Authors:  Jong-Young Lee; Seung-Whan Lee; Woo Seok Lee; Seungbong Han; Yong Kyu Park; Chang Hee Kwon; Jeong Yoon Jang; Young-Rak Cho; Gyung-Min Park; Jung-Min Ahn; Won-Jang Kim; Duk-Woo Park; Soo-Jin Kang; Young-Hak Kim; Cheol Whan Lee; Seong-Wook Park; Seung-Jung Park
Journal:  JACC Cardiovasc Interv       Date:  2013-12       Impact factor: 11.195

Review 3.  The ankle-brachial index for peripheral artery disease screening and cardiovascular disease prediction among asymptomatic adults: a systematic evidence review for the U.S. Preventive Services Task Force.

Authors:  Jennifer S Lin; Carin M Olson; Eric S Johnson; Evelyn P Whitlock
Journal:  Ann Intern Med       Date:  2013-09-03       Impact factor: 25.391

4.  Bilateral internal thoracic artery grafting for peripheral arterial disease patients.

Authors:  Taro Nakatsu; Nobushige Tamura; Shigeki Yanagi; Shoichi Kyo; Takaaki Koshiji; Ryuzo Sakata
Journal:  Gen Thorac Cardiovasc Surg       Date:  2014-01-23

5.  Comparison of mortality in patients with coronary or peripheral artery disease following the first vascular intervention.

Authors:  David Pereg; Avishay Elis; Yoram Neuman; Morris Mosseri; David Segev; Martine Granek-Catarivas; Michael Lishner; Doron Hermoni
Journal:  Coron Artery Dis       Date:  2014-01       Impact factor: 1.439

6.  Mortality over a period of 10 years in patients with peripheral arterial disease.

Authors:  M H Criqui; R D Langer; A Fronek; H S Feigelson; M R Klauber; T J McCann; D Browner
Journal:  N Engl J Med       Date:  1992-02-06       Impact factor: 91.245

7.  ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC).

Authors:  Michal Tendera; Victor Aboyans; Marie-Louise Bartelink; Iris Baumgartner; Denis Clément; Jean-Philippe Collet; Alberto Cremonesi; Marco De Carlo; Raimund Erbel; F Gerry R Fowkes; Magda Heras; Serge Kownator; Erich Minar; Jan Ostergren; Don Poldermans; Vincent Riambau; Marco Roffi; Joachim Röther; Horst Sievert; Marc van Sambeek; Thomas Zeller
Journal:  Eur Heart J       Date:  2011-08-26       Impact factor: 29.983

8.  Peripheral artery disease and risk of cardiovascular events in patients with coronary artery disease: insights from the Heart and Soul Study.

Authors:  S Marlene Grenon; Eric Vittinghoff; Christopher D Owens; Michael S Conte; Mary Whooley; Beth E Cohen
Journal:  Vasc Med       Date:  2013-07-08       Impact factor: 3.239

Review 9.  Peripheral artery disease and chronic kidney disease: clinical synergy to improve outcomes.

Authors:  Pranav S Garimella; Alan T Hirsch
Journal:  Adv Chronic Kidney Dis       Date:  2014-10-24       Impact factor: 3.620

10.  Prognostic value of functional performance for mortality in patients with peripheral artery disease.

Authors:  Mary M McDermott; Lu Tian; Kiang Liu; Jack M Guralnik; Luigi Ferrucci; Jin Tan; William H Pearce; Joseph R Schneider; Michael H Criqui
Journal:  J Am Coll Cardiol       Date:  2008-04-15       Impact factor: 24.094

View more
  1 in total

1.  Impact of established cardiovascular disease on 10-year death after coronary revascularization for complex coronary artery disease.

Authors:  Rutao Wang; Scot Garg; Chao Gao; Hideyuki Kawashima; Masafumi Ono; Hironori Hara; Robert-Jan van Geuns; Marie-Claude Morice; Piroze M Davierwala; Arie Pieter Kappetein; David R Holmes; William Wijns; Ling Tao; Yoshinobu Onuma; Patrick W Serruys
Journal:  Clin Res Cardiol       Date:  2021-08-25       Impact factor: 5.460

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.